Literature DB >> 27427916

Severe hepatitis C reactivation as an early complication of hematopoietic cell transplantation.

N T Oliver1, Y L Nieto2, B Blechacz3, P Anderlini2, E Ariza-Heredia4, H A Torres4.   

Abstract

Mesh:

Year:  2016        PMID: 27427916     DOI: 10.1038/bmt.2016.196

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


× No keyword cloud information.
  13 in total

Review 1.  Hepatitis C Virus Infection among Hematopoietic Cell Transplant Donors and Recipients: American Society for Blood and Marrow Transplantation Task Force Recommendations.

Authors:  Harrys A Torres; Pearlie P Chong; Marcos De Lima; Mark S Friedman; Sergio Giralt; Sarah P Hammond; Patrick J Kiel; Henry Masur; George B McDonald; John R Wingard; Maya Gambarin-Gelwan
Journal:  Biol Blood Marrow Transplant       Date:  2015-08-06       Impact factor: 5.742

2.  Effect of hepatitis C virus infection in patients with cancer: addressing a neglected population.

Authors:  Harrys A Torres; Parag Mahale; Boris Blechacz; Ethan Miller; Ahmed Kaseb; H Franklin Herlong; Nathan Fowler; Ying Jiang; Issam I Raad; Dimitrios P Kontoyiannis
Journal:  J Natl Compr Canc Netw       Date:  2015-01       Impact factor: 11.908

3.  Hepatitis C Virus Infection in Patients Undergoing Hematopoietic Cell Transplantation in the Era of Direct-Acting Antiviral Agents.

Authors:  Andreas Kyvernitakis; Parag Mahale; Uday R Popat; Ying Jiang; Jeff Hosry; Richard E Champlin; Harrys A Torres
Journal:  Biol Blood Marrow Transplant       Date:  2015-12-19       Impact factor: 5.742

4.  Acute exacerbation and reactivation of chronic hepatitis C virus infection in cancer patients.

Authors:  Parag Mahale; Dimitrios P Kontoyiannis; Roy F Chemaly; Ying Jiang; Jessica P Hwang; Marta Davila; Harrys A Torres
Journal:  J Hepatol       Date:  2012-08-04       Impact factor: 25.083

Review 5.  Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection.

Authors:  H E Kohrt; D L Ouyang; E B Keeffe
Journal:  Aliment Pharmacol Ther       Date:  2006-10-01       Impact factor: 8.171

6.  Recommendations for the identification of chronic hepatitis C virus infection among persons born during 1945-1965.

Authors:  Bryce D Smith; Rebecca L Morgan; Geoff A Beckett; Yngve Falck-Ytter; Deborah Holtzman; Chong-Gee Teo; Amy Jewett; Brittney Baack; David B Rein; Nita Patel; Miriam Alter; Anthony Yartel; John W Ward
Journal:  MMWR Recomm Rep       Date:  2012-08-17

7.  Fibrosing cholestatic hepatitis C after hematopoietic cell transplantation: report of 3 fatal cases.

Authors:  Ashley T Evans; Keith R Loeb; Howard M Shulman; Sajida Hassan; Wan Chong Qiu; David M Hockenbery; George N Ioannou; Thomas R Chauncey; David R Gretch; George B McDonald
Journal:  Am J Surg Pathol       Date:  2015-02       Impact factor: 6.394

8.  Impact of hepatitis C virus seropositivity on survival after allogeneic hematopoietic stem cell transplantation for hematologic malignancies.

Authors:  Carlos A Ramos; Rima M Saliba; Leandro de Pádua; Ola Khorshid; Elizabeth J Shpall; Sergio Giralt; Poliana A Patah; Chitra M Hosing; Uday R Popat; Gabriela Rondon; Issa F Khouri; Yago L Nieto; Richard E Champlin; Marcos de Lima
Journal:  Haematologica       Date:  2009-01-14       Impact factor: 9.941

9.  Long-term outcome of hepatitis C infection after bone marrow transplantation.

Authors:  Régis Peffault de Latour; Vincent Lévy; Tarik Asselah; Patrick Marcellin; Catherine Scieux; Lionel Adès; Richard Traineau; Agnès Devergie; Patricia Ribaud; Hélène Espérou; Eliane Gluckman; Dominique Valla; Gérard Socié
Journal:  Blood       Date:  2003-10-23       Impact factor: 22.113

10.  Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders.

Authors:  F Silvestri; C Pipan; G Barillari; F Zaja; R Fanin; L Infanti; D Russo; E Falasca; G A Botta; M Baccarani
Journal:  Blood       Date:  1996-05-15       Impact factor: 22.113

View more
  4 in total

1.  Hepatitis C virus reactivation in patients receiving cancer treatment: A prospective observational study.

Authors:  Harrys A Torres; Jeff Hosry; Parag Mahale; Minas P Economides; Ying Jiang; Anna S Lok
Journal:  Hepatology       Date:  2017-11-13       Impact factor: 17.425

Review 2.  The oncologic burden of hepatitis C virus infection: A clinical perspective.

Authors:  Harrys A Torres; Terri Lynn Shigle; Nassim Hammoudi; James T Link; Felipe Samaniego; Ahmed Kaseb; Vincent Mallet
Journal:  CA Cancer J Clin       Date:  2017-07-06       Impact factor: 508.702

3.  How I treat hepatitis C virus infection in patients with hematologic malignancies.

Authors:  Harrys A Torres; George B McDonald
Journal:  Blood       Date:  2016-07-21       Impact factor: 22.113

4.  Effects of dual plasma molecular adsorption system on liver function, electrolytes, inflammation, and immunity in patients with chronic severe hepatitis.

Authors:  Gao Chen; Mengzheng Wu; Bibo Wu; Feifei Liu; Jianying Liu; Li Liu
Journal:  J Clin Lab Anal       Date:  2019-06-17       Impact factor: 2.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.